The association between tricuspid regurgitation velocity and 5‐year survival in a North West London population of patients with sickle cell disease in the United Kingdom

Raised tricuspid regurgitant velocity (TRV) occurs in approximately 30% of adults with sickle cell disease (SCD), and has been shown to be an independent risk factor for death. TRV was assessed in 164 SCD patients who were subsequently followed up for survival. Raised pulmonary pressures were defined as a TRV jet ≥2·5 m/s on echocardiography. Elevated TRV was present in 29·1% of patients and it was associated with increased age and left atrial diameter. There were 15 deaths (9·1%) over a median of 68·1 months follow up; seven patients had increased TRV, and eight patients had a TRV<2·5 m/s. Higher TRV values were associated with a greater than 4‐fold increased risk of death (Hazard Ratio: 4·48, 99% confidence interval 1·01‐19·8), although we found a lower overall mortality rate than has been reported in previous studies. TRV was not an independent risk factor for death. We have confirmed the association between raised TRV and mortality in a UK SCD population whose disease severity appears to be less than that reported in previous studies. Further prospective studies are needed to more clearly characterize which patient factors modify survival in SCD patients with raised TRV.

[1]  J. Stockman,et al.  A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease , 2013 .

[2]  M. Gladwin,et al.  Risk Factors for Death in 632 Patients with Sickle Cell Anemia in the United States and United Kingdom , 2012 .

[3]  V. Salemi,et al.  Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease , 2011, European Respiratory Journal.

[4]  L. Savale,et al.  A hemodynamic study of pulmonary hypertension in sickle cell disease. , 2011, The New England journal of medicine.

[5]  D. Spevack,et al.  An Elevated Estimated Pulmonary Arterial Systolic Pressure, Whenever Measured, Is Associated with Excess Mortality in Adults with Sickle Cell Disease , 2011, Acta Haematologica.

[6]  M. Gladwin,et al.  Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective. , 2010, Chest.

[7]  M. Telen,et al.  Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease , 2009, American journal of hematology.

[8]  C. Quinn,et al.  Improved survival of children and adolescents with sickle cell disease. , 2008, Blood.

[9]  O. Bech-Hanssen,et al.  Doppler echocardiography can provide a comprehensive assessment of right ventricular afterload. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  James B. Seward,et al.  Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. , 2008, Journal of the American College of Cardiology.

[11]  A. Ashley-Koch,et al.  Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes , 2008, American journal of hematology.

[12]  A. Thompson,et al.  Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension , 2007, Haematologica.

[13]  M. Cairo,et al.  Pulmonary hypertension in sickle cell disease. , 2007, Clinical advances in hematology & oncology : H&O.

[14]  F. Kirkham,et al.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. , 2007, Haematologica.

[15]  Vandana Sachdev,et al.  Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. , 2007, American journal of respiratory and critical care medicine.

[16]  F. Yalçin,et al.  Pulmonary Hypertension in Sickle-Cell Disease: Comorbidities and Echocardiographic Findings , 2007, Acta Haematologica.

[17]  C. Moore,et al.  Pulmonary hypertension in patients with sickle cell disease: a longitudinal study , 2006, British journal of haematology.

[18]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  A. Ashley-Koch,et al.  Pulmonary Hypertension in SS, SC and Sβ Thalassemia: Prevalence, Associated Clinical Syndromes, and Mortality. , 2004 .

[20]  K. Ataga,et al.  Pulmonary hypertension in sickle cell disease. , 2004, The American journal of medicine.

[21]  J. Gardin,et al.  American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[22]  J. Krishnan,et al.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.

[23]  M. Gladwin,et al.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.

[24]  R. Ware,et al.  Malignancy in patients with sickle cell disease , 2003, American journal of hematology.

[25]  O. Castro,et al.  Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. , 2003, Blood.

[26]  C. Klersy,et al.  Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure. , 2002, American heart journal.

[27]  C. Otto,et al.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  M. Hickman,et al.  Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic‐specific rates , 1999, British journal of haematology.

[29]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[30]  J. Niland,et al.  Sickle Cell Chronic Lung Disease: Prior Morbidity and the Risk of Pulmonary Failure , 1988, Medicine.

[31]  B. Angelsen,et al.  Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. , 1981, British heart journal.